BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260610T201541
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261122
DTSTAMP:20260610T201541
CREATED:20260302T042655Z
LAST-MODIFIED:20260302T042655Z
UID:10000258-1795046400-1795305599@melanoma.org.au
SUMMARY:Australasian Melanoma Conference
DESCRIPTION:The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research\, diagnosis\, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians\, researchers\, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration. \nThe AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of: \n\nPrevention\nEarly Detection\nAdvanced Diseases\nSurvivorship\n\nLocation: Sofitel Melbourne on Collins\, Melbourne\, Australia \nKey Dates: \nConference Dates: 19 November 2026 – 21 November 2026\nEarly Bird Registration Deadline: 31 July 2026\nAbstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST) \nFIND OUT MORE
URL:https://melanoma.org.au/event/amc-2026/
LOCATION:Sofitel Melbourne on Collins\, 25 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/AMC-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261204
DTSTAMP:20260610T201541
CREATED:20260602T054510Z
LAST-MODIFIED:20260602T054510Z
UID:10000296-1795996800-1796342399@melanoma.org.au
SUMMARY:Melanoma and Immunotherapy Bridge
DESCRIPTION:Upcoming annual appointments for worldwide cancer clinicians and researchers\, gaining more and more attendees every year\, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd\, respectively. \nThe first session of Immunotherapy Bridge will be jointly organized with the Society for ImmunoTherapy of Cancer and dedicated to the Modulator of Tumor Immunity and Immunotherapy. An in depth analysis of the drivers of organ specific immune response\, the novel drugs development\, the actual landscape and future perspectives on the field of cancer vaccines and the neoadjuvant therapies across cancers will follow. \nThe scientific program of Melanoma Bridge will be dedicated to the most pressing of the unanswered questions\, the translational research in melanoma and the most valuable emerging strategies. \nBoth Immunotherapy and Melanoma Bridge meetings will host a “Great Debate” session\, where counterpoint views from leading experts on specific controversial clinical issues will be presented\, discussed and evaluated by the audience. \n\n\n\n\n\n\nLocation: Royal Continental Hotel Naples\, Italy \n\n\n\n\n\nKey Dates \nAbstract Submission Deadline: 5 October 2026\nAbstract Decision Notification: 30 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/melanoma-immunotherapy-bridge/
LOCATION:Royal Continental Hotel Naples\, Via Partenope 38/44\, Naples\, 80121\, Italy
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Melanoma_Bridge600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261205
DTSTAMP:20260610T201541
CREATED:20260602T053522Z
LAST-MODIFIED:20260602T053522Z
UID:10000295-1795996800-1796428799@melanoma.org.au
SUMMARY:ASI Annual Scientific Meeting
DESCRIPTION:The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI)\, to be held 30 November – 4 December 2026 in Canberra (Ngunnawal Country)\, Australia’s national capital. \nSet in one of the world’s most sustainable and liveable cities\, Canberra offers the perfect setting for a week of discovery\, connection\, and scientific excellence. Our comprehensive program will spotlight the leading immunological research from Australia\, New Zealand and around the world. The program will include a wide range of topics covering cutting-edge fundamental\, translational\, and clinical immunology—from infection\, inflammation\, and autoimmunity to tumour immunology\, and immunometabolism. \nOur meeting venue\, QT Canberra\, provides an intimate environment designed to support vibrant discussion and collaboration. Set close to the city centre\, on the shores of Lake Burley Griffin\, you will be within easy reach to a thriving food and wine scene\, national museums and galleries and scenic outdoor spaces providing every opportunity to immerse yourself in the best Canberra has to offer. \nWe look forward to welcoming you to ASI 2026 in Canberra—a meeting that promises rich scientific exchange\, renewed connections\, and an engaging celebration of our immunology community. \n\n\n\n\n\nLocation: QT Canberra\, Canberra\, Australia \nKey Dates: \nAbstract Submission Deadline: mid-late August 2026\nAbstract Decision Notification: Sep – Oct 2026\nEarly Bird Registration Deadline: mid-late August 2026\nStandard Registration Deadline: 23 November 2026 \n\n\n\n\n\nFIND OUT MORE
URL:https://melanoma.org.au/event/asi-annual-meeting/
LOCATION:QT Canberra\, 1 London Cct\, Canberra\, 2601\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/ASI_2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR